Oncotelic Therapeutics, Inc. is focused on developing innovative therapies for cancer treatment, primarily through the use of immunotherapy. The company's key products include novel therapeutic agents designed to enhance the immune response against tumor cells, with a particular emphasis on maximizing patient outcomes in oncology. Its operations are primarily based in the United States, with plans to explore global markets for its therapies. As a mid-sized biopharmaceutical company, Oncotelic is actively involved in clinical trials and research initiatives aimed at advancing its drug pipeline and expanding its therapeutic reach.
Fundz sees it the moment Oncotelic Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Agoura HillsBiotechnologyHealthcareHealth CareTherapeutics